ERIN DEBRUYN: Open Payments
NPI 1679832539 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$804 in 39 payments from 9 companies in 2025. Trend: 2023 $723 · 2024 $906 · 2025 $804
Food & beverage: $804
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 10 | $227 |
| Biogen, Inc. | 8 | $173 |
| MILLICENT US INC | 5 | $83 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $77 |
| ABBVIE INC. | 3 | $73 |
| MAYNE PHARMA COMMERCIAL LLC | 3 | $65 |
| Exeltis, USA Inc. | 3 | $48 |
| Sumitomo Pharma America, Inc. | 3 | $42 |
| PFIZER INC. | 1 | $16 |
Products named: Veozah, ZURZUVAE, QULIPTA, INTRAROSA, Lynkuet, SLYND, MYFEMBREE, FEMLYV.
Industry payments across TN — which companies pay providers there.
